SAD and MAD of VENT-02 in healthy volunteers
This study is called 'SAD and MAD of VENT-02' and is looking at a brand-new medicine known as VENT-02. This is a very early stage of research, meaning it's the first time this medicine is being given to humans. We're testing it in healthy volunteers, which means people who don't have any major health problems. The main goal is to see how safe VENT-02 is and how the body handles it. Understanding this is a really important first step. Medicines like VENT-02 could one day help people with serious brain conditions where there's swelling or damage, but this study isn't looking at treating those conditions yet. It's all about making sure the medicine is safe enough to study further.
At a glance
What is this study about?
This study, called 'SAD and MAD of VENT-02,' is about a new medicine named VENT-02. It's a very early-stage study, often called a 'Phase 1' study. This means it's the first time researchers are giving this medicine to people. The main purpose of this initial research is to find out if the medicine is safe and how the body handles it. Researchers will be looking at things like what happens to the medicine once it's in the body, how quickly it leaves, and if it causes any unwanted effects.
To understand the safety and how the medicine works, the study uses healthy volunteers. These are people who generally don't have any significant health issues. By studying healthy people first, researchers can get a clear picture of the medicine's basic effects without confusing them with symptoms of an illness. This is a crucial step before they can even think about testing the medicine in people who are unwell.
The medicine called VENT-02 is being developed because it might be helpful for serious brain conditions in the future. These conditions include issues where there's swelling or damage in the brain. However, it's very important to know that this current study is *not* testing whether VENT-02 can treat these conditions. It's purely focused on its safety and how it behaves in the human body. If this first study goes well and the medicine is found to be safe, then it might be tested in later studies to see if it can actually help people with those serious brain conditions.
Key takeaways
- This is a very early and important safety test of a new medicine (VENT-02).
- It involves healthy volunteers (people who are generally well).
- The main aim is to check if the medicine is safe and how the body handles it.
- There's no direct health benefit for volunteers, but it helps future patients.
- You'll have regular health check-ups and monitoring if you take part.
- You can stop participating at any time.
Who may be eligible?
To take part in this study, you need to be an adult, which means you must be 18 years old or older. There is no upper age limit, so people of all adult ages can be considered.
Both men and women are welcome to take part in this study. The researchers want to include a diverse group of people to make sure the findings are relevant to everyone.
Because this is a very early study looking at safety, you will need to be in generally good health. This means you shouldn't have any major underlying medical conditions that could make taking the new medicine risky or affect how the researchers understand its effects.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you a man or a woman?
- Are you generally in good health?
- Do you have any major medical conditions?
- Are you able to attend regular clinic visits, including overnight stays?
What does participation involve?
Taking part in this study would involve a number of visits to the clinic, usually requiring you to stay overnight for some of them. During these visits, nurses and doctors will check your health carefully. This will include things like blood tests, urine tests, checking your heart with an ECG, and monitoring your blood pressure and heart rate. You will be given doses of the study medicine, VENT-02, which you'll take by mouth or by injection, as instructed by the study team. After you take the medicine, there will be follow-up appointments, often involving more blood tests, to see how your body is handling the medicine and if there are any side effects. The total duration of your involvement could range from a few weeks to a couple of months, depending on the specific schedule of the study.
Potential risks and benefits
Locations (1)
- —UnverifiedNetherlands
Common questions
What does 'healthy volunteer' mean?
It means you don't have any major illnesses and are generally well, so researchers can see how the new medicine affects a typical healthy person.
Will I get better if I join this study?
No, this study is about checking the safety of a new medicine, not treating any illness. There's no direct health benefit for you.
How long will I need to be involved in the study?
The study usually involves a series of visits over several weeks or a couple of months, including some overnight stays.
What kind of tests will I have?
You'll have regular medical checks, blood tests, urine tests, and heart monitoring (ECG) to make sure you're safe.
Can I leave the study if I change my mind?
Yes, you can leave the study at any time, for any reason, and it won't affect your normal medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.